Skip to Main Content

Paper Details

SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations.
Cell Rep
18
2022
CoV-, S1 antibodies, S1- and, S2-reactive antibodies, SARS, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 mRNA, SARS-CoV-2 spike-reactive antibodies, antigenic, antigenic sin-like antibodies, health care workers, human, mRNA, participants, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, sin antibodies, spike
Author NameAffiliation
Rishi R GoelInstitute for Immunology, Perelman School of Medicine, University of Pennsylvania
Ian FrankPerelman School of Medicine, University of Pennsylvania
Daniel J RaderInstitute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania
  • 1 - 3

Datasets

Release 1.2